|
DNAJB9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.787400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.450000E-01 |
| Normal-vs-Stage2 |
5.635800E-01 |
| Normal-vs-Stage3 |
5.291800E-01 |
| Normal-vs-Stage4 |
6.942100E-02 |
| Stage1-vs-Stage2 |
3.801400E-01 |
| Stage1-vs-Stage3 |
8.562000E-01 |
| Stage1-vs-Stage4 |
7.620300E-02 |
| Stage2-vs-Stage3 |
3.614000E-01 |
| Stage2-vs-Stage4 |
8.286400E-02 |
| Stage3-vs-Stage4 |
2.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.512600E-01 |
| Normal-vs-AfricanAmerican |
9.068200E-01 |
| Normal-vs-Asian |
4.473600E-01 |
| Caucasian-vs-AfricanAmerican |
5.620400E-01 |
| Caucasian-vs-Asian |
4.322000E-01 |
| AfricanAmerican-vs-Asian |
6.005600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.475800E-01 |
| Normal-vs-Female |
9.114800E-01 |
| Male-vs-Female |
8.474000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.591800E-01 |
| Normal-vs-Extreme_Weight |
6.397000E-01 |
| Normal-vs-Obese |
8.201400E-01 |
| Normal-vs-Extreme_Obese |
9.971200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.088800E-01 |
| Normal_Weight-vs-Obese |
2.634600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.896400E-01 |
| Extreme_Weight-vs-Obese |
4.902000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.214800E-01 |
| Obese-vs-Extreme_Obese |
9.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.857000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.995000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.376800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.131000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.978200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.764400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.320400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.114620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.165800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.006200E-01 |
| Normal-VS-Type2 PRCC |
3.697400E-01 |
| Normal-VS-KIRP CIMP |
9.735800E-02 |
| Normal-VS-Unclassified PRCC |
5.599600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.753500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.065200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.933440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.118600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.214400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.969600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.027800E-01 |
| Normal-vs-N1 |
2.338200E-01 |
| Normal-vs-N2 |
2.187400E-01 |
| N0-vs-N1 |
4.535800E-01 |
| N0-vs-N2 |
4.558000E-02 |
| N1-vs-N2 |
3.559400E-01 |
|
|
